Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant TCP1 alpha/CCTA anticorps (AA 1-200)

L’anticorps anti-TCP1 alpha/CCTA Monoclonal Souris est utilisé pour la détection de TCP1 alpha/CCTA dans des échantillons de Humain. Il a été validé pour IHC.
N° du produit ABIN7857933
639,45 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination: France
Envoi sous 6 à 10 jours ouvrables

Aperçu rapide pour Recombinant TCP1 alpha/CCTA anticorps (AA 1-200) (ABIN7857933)

Antigène

Voir toutes TCP1 alpha/CCTA (TCP1) Anticorps
TCP1 alpha/CCTA (TCP1) (T-Complex 1 (TCP1))

Type d'anticorp

Recombinant Antibody

Reactivité

  • 249
  • 152
  • 100
  • 21
  • 21
  • 20
  • 19
  • 17
  • 17
  • 15
  • 13
  • 11
  • 10
  • 4
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Humain

Hôte

  • 192
  • 59
  • 26
  • 1
  • 1
Souris

Clonalité

  • 143
  • 136
Monoclonal

Conjugué

  • 101
  • 18
  • 10
  • 8
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
Cet anticorp TCP1 alpha/CCTA est non-conjugé

Application

  • 154
  • 98
  • 69
  • 69
  • 53
  • 52
  • 49
  • 43
  • 42
  • 41
  • 35
  • 12
  • 11
  • 1
  • 1
Immunohistochemistry (IHC)

Clone

RP40-8765
  • Épitope

    • 40
    • 18
    • 18
    • 15
    • 15
    • 15
    • 15
    • 11
    • 10
    • 5
    • 5
    • 5
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-200

    Fonction

    Recombinant p63 (Squamous, Basal & Myoepithelial Cell Marker) Antibody

    Specificité

    P63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands, however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90 % . Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80 %. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts.

    Purification

    200ug/ml of Ab purified by Protein A Column.

    Immunogène

    Recombinant fragment (around aa1-200) of human TP63 protein (exact sequence is proprietary)

    Isotype

    IgG2a, kappa
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10  mM PBS

    Agent conservateur

    Azide free

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C.Antibody is stable for 24 months. Non-hazardous. No MSDS required.
  • Antigène

    TCP1 alpha/CCTA (TCP1) (T-Complex 1 (TCP1))

    Autre désignation

    p63

    Sujet

    Amplified in squamous cell carcinoma (AIS), Chronic ulcerative stomatitis protein (CUSP), EEC3, Keratinocyte transcription factor KET, LMS, NBP, p40, P51/P63, p53 like transcription factor, p53-related protein p63, RHS, SHFM4, TAp63alpha, TP53CP, TP53L, TP63, TP73, TP73L, Transformation-related protein 63, Trp53rp1, Trp6,3

    Human prostate|lung or bladder squamous cell carcinoma tissue.

    Poids moléculaire

    63kDa

    ID gène

    8626, 137569

    UniProt

    Q9H3D4
Vous êtes ici:
Chat with us!